Common Approaches to the Control of Multidrug-resistant Organisms Other Than Methicillin-resistant Staphylococcus aureus (MRSA)

Infectious Disease Clinics of North America

Volumn 25, Issue 1, 2011, Pages 181-200

  Hebert, Courtney ^a   Weber, Stephen G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Clostridium difficile; Multidrug resistant gram negative infection; Multidrug resistant organisms; Vancomycin resistant enterococcus

Indexed keywords

ALCOHOL; AMOXICILLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; DRUG EXPOSURE; DRUG USE; ENTEROCOCCAL INFECTION; EPIDEMIC; GRAM NEGATIVE INFECTION; HAND WASHING; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PNEUMONIA; PREVALENCE; PROTECTIVE EQUIPMENT; PSEUDOMONAS INFECTION; REVIEW; SEPSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN RESISTANCE;

EID: 79551693071     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2010.11.006     Document Type: Review

References (112)

1. Zell B.L., Goldmann D.A. Healthcare-associated infection and antimicrobial resistance: moving beyond description to prevention. Infect Control Hosp Epidemiol 2007, 28(3):261-264.
2. National Nosocomial Infections Surveillance System National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32(8):470-485.
3. Leclercq R., Derlot E., Duval J., et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988, 319(3):157-161.
4. Vergis E.N., Hayden M.K., Chow J.W., et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 2001, 135(7):484-492.
5. Rahim S., Pillai S.K., Gold H.S., et al. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis 2003, 36(11):E146-E148.
6. Gaynes R., Edwards J.R., National Nosocomial Infections Surveillance System Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41(6):848-854. [see comment].
7. Boucher H.W., Talbot G.H., Bradley J.S., et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48(1):1-12.
8. Shorr A.F. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 2009, 37(4):1463-1469.
9. Peralta G., Sanchez M.B., Garrido J.C., et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 2007, 60(4):855-863.
10. Gerding D.N. Editorial commentary: clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004, 38(5):646-648.
11. Hoberman L.J., Eigenbrodt E.H., Kilman W.J., et al. Colitis associated with oral clindamycin therapy. A clinical study of 16 patients. Am J Dig Dis 1976, 21(1):1-17.
12. Kelly C.P., LaMont J.T. Clostridium difficile-more difficult than ever. N Engl J Med 2008, 359(18):1932-1940.
13. McDonald L.C., Owings M., Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006, 12(3):409-415.
14. Salazar M., Baskin L., Garey K.W., et al. Clostridium difficile-related death rates in Texas 1999-2005. J Infect 2009, 59(5):303-307.
15. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005, 353(23):2433-2441.
16. Price P.B. The bacteriology of normal skin, a new quantitative test applied to a study of the bacterial flora and the disinfectant action of mechanical cleansing. J Infect Dis 1938, 63:301-318.
17. Lin Y.C., Lauderdale T.L., Lin H.M., et al. An outbreak of methicillin-resistant Staphylococcus aureus infection in patients of a pediatric intensive care unit and high carriage rate among health care workers. J Microbiol Immunol Infect 2007, 40(4):325-334.
18. Singh D., Kaur H., Gardner W.G., et al. Bacterial contamination of hospital pagers. Infect Control Hosp Epidemiol 2002, 23(5):274-276.
19. Treakle A.M., Thom K.A., Furuno J.P., et al. Bacterial contamination of health care workers' white coats. Am J Infect Control 2009, 37(2):101-105.
20. Borer A., Gilad J., Smolyakov R., et al. Cell phones and Acinetobacter transmission. Emerg Infect Dis 2005, 11(7):1160-1161.
21. Podnos Y.D., Cinat M.E., Wilson S.E., et al. Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect (Larchmt) 2001, 2(4):297-301.
22. Kramer A., Schwebke I., Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006, 6:130.
23. Huang S.S., Datta R., Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006, 166(18):1945-1951.
24. Stiefel U., Pultz N.J., Donskey C.J. Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 2007, 51(1):372-375.
25. Pultz N.J., Stiefel U., Donskey C.J. Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 2005, 49(8):3513-3516.
26. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003, 24(5):362-386.
27. Willemsen I., Groenhuijzen A., Bogaers D., et al. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother 2007, 51(3):864-867.
28. Miller Y.W., Eady E.A., Lacey R.W., et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996, 38(5):829-837.
29. Noakes T.D., Borresen J., Hew-Butler T., et al. Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review. Epidemiol Infect 2008, 136(1):1-9.
30. Pittet D., Hugonnet S., Harbarth S., et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000, 356(9238):1307-1312.
31. Boyce J.M., Pittet D. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 2002, 23(Suppl 12):S3-S40.
32. Rupp M.E., Fitzgerald T., Puumala S., et al. Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infect Control Hosp Epidemiol 2008, 29(1):8-15.
33. Lankford M.G., Collins S., Youngberg L., et al. Assessment of materials commonly utilized in health care: implications for bacterial survival and transmission. Am J Infect Control 2006, 34(5):258-263.
34. Hayden M.K., Blom D.W., Lyle E.A., et al. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol 2008, 29(2):149-154.
35. Bonilla H.F., Zervos M.A., Lyons M.J., et al. Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol 1997, 18(5):333-339.
36. Noskin G.A., Stosor V., Cooper I., et al. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995, 16(10):577-581.
37. Gaonkar T.A., Geraldo I., Caraos L., et al. An alcohol hand rub containing a synergistic combination of an emollient and preservatives: prolonged activity against transient pathogens. J Hosp Infect 2005, 59(1):12-18.
38. Austin D.J., Bonten M.J.M., Weinstein R.A., et al. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A 1999, 96(12):6908-6913.
39. Larson E.L., Early E., Cloonan P., et al. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav Med 2000, 26(1):14-22.
40. Fryklund B., Tullus K., Burman L.G. Survival on skin and surfaces of epidemic and nonepidemic strains of enterobacteria from neonatal special care units. J Hosp Infect 1995, 29(3):201-208.
41. Larson E.L. Persistent carriage of gram-negative bacteria on hands. Am J Infect Control 1981, 9(4):112-119.
42. Pottinger J., Burns S., Manske C. Bacterial carriage by artificial versus natural nails. Am J Infect Control 1989, 17(6):340-344.
43. Pitten F.A., Panzig B., Schröder G., et al. Transmission of a multiresistant Pseudomonas aeruginosa strain at a German University Hospital. J Hosp Infect 2001, 47(2):125-130.
44. Gill C.J., Mantaring J.B., Macleod W.B., et al. Impact of enhanced infection control at 2 neonatal intensive care units in the Philippines. Clin Infect Dis 2009, 48(1):13-21.
45. Bacon A.E., Fekety R., Schaberg D.R., et al. Epidemiology of Clostridium difficile colonization in newborns: results using a bacteriophage and bacteriocin typing system. J Infect Dis 1988, 158(2):349-354.
46. Boyce J.M., Pittet D. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51(RR-16):1-45. [quiz: CE1-4].
47. Oughton M.T., Loo V.G., Dendukuri N., et al. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol 2009, 30(10):939-944.
48. Gordin F.M., Schultz M.E., Huber R.A., et al. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol 2005, 26(7):650-653.
49. Vernaz N., Sax H., Pittet D., et al. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 2008, 62(3):601-607.
50. Boyce J.M., Ligi C., Kohan C., et al. Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 2006, 27(5):479-483.
51. Abbett S.K., Yokoe D.S., Lipsitz S.R., et al. Original article: proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009, 30(11):1062-1069.
52. Dubberke E.R., Gerding D.N., Classen D., et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S81-S92.
53. Gensini G.F., Yacoub M.H., Conti A.A. The concept of quarantine in history: from plague to SARS. J Infect 2004, 49(4):257-261.
54. Olsen R.J., Lynch P., Coyle M.B., et al. Examination gloves as barriers to hand contamination in clinical practice. JAMA 1993, 270(3):350-353.
55. Jernigan J.A., Titus M.G., Groschel D.H., et al. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996, 143(5):496-504.
56. Cooper B.S., Stone S.P., Kibbler C.C., et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004, 329(7465):533.
57. Siegel J.D., Rhinehart E., Jackson M., et al. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007, 35(10 Suppl 2):S65-S164.
58. Zachary K.C., Bayne P.S., Morrison V.J., et al. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2001, 22(9):560-564.
59. Tenorio Allan R., Badri Sheila M., Sahgal Nishi B., et al. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis 2001, 32(5):826-829.
60. Kurup A., Chlebicki M.P., Ling M.L., et al. Control of a hospital-wide vancomycin-resistant enterococci outbreak. Am J Infect Control 2008, 36(3):206-211.
61. Aumeran C., Baud O., Lesens O., et al. Successful control of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in France. Eur J Clin Microbiol Infect Dis 2008, 27(11):1061-1064.
62. Ostrowsky B.E., Trick W.E., Sohn A.H., et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001, 344(19):1427-1433.
63. Servais A., Mercadal L., Brossier F., et al. Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department. Clin J Am Soc Nephrol 2009, 4(10):1559-1564.
64. Srinivasan A., Song X., Ross T., et al. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol 2002, 23(8):424-428.
65. Puzniak L.A., Leet T., Mayfield J., et al. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2002, 35(1):18-25.
66. Gbaguidi-Haore H., Legast S., Thouverez M., et al. Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii. Infect Control Hosp Epidemiol 2008, 29(12):1118-1123.
67. Conterno L.O., Shymanski J., Ramotar K., et al. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum [beta]-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect 2007, 65(4):354-360.
68. Laurent C., Rodriguez-Villalobos H., Rost F., et al. Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 2008, 29(6):517-524.
69. Yokoe D.S., Mermel L.A., Anderson D.J., et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S12-S21.
70. Zafar A.B., Gaydos L.A., Furlong W.B., et al. Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control 1998, 26(6):588-593.
71. Johnson S., Gerding D.N., Olson M.M., et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990, 88(2):137-140.
72. Salgado C.D., Mauldin P.D., Fogle P.J., et al. Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures. Am J Infect Control 2009, 37(6):458-464.
73. Stelfox H.T., Bates D.W., Redelmeier D.A. Safety of patients isolated for infection control. JAMA 2003, 290(14):1899-1905.
74. Catalano G., Houston S.H., Catalano M.C., et al. Anxiety and depression in hospitalized patients in resistant organism isolation. South Med J 2003, 96(2):141-145.
75. Harris A.D., McGregor J.C., Furuno J.P. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?. Clin Infect Dis 2006, 43(Suppl 2):S57-S61.
76. Huang S.S., Yokoe D.S., Hinrichsen V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006, 43(8):971-978.
77. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008, 148(6):409-418.
78. Ostrowsky B.E., Venkataraman L., D'Agata E.M., et al. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med 1999, 159(13):1467-1472.
79. Byers K.E., Anglim A.M., Anneski C.J., et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001, 22(3):140-147.
80. Price C.S., Paule S., Noskin G.A., et al. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 2003, 37(7):921-928.
81. Papadomichelakis E., Kontopidou F., Antoniadou A., et al. Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection. Intensive Care Med 2008, 34(12):2169-2175.
82. Centers for Disease Control and Prevention (CDC) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009, 58(10):256-260.
83. Gardam M.A., Burrows L.L., Kus J.V., et al. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak?. J Infect Dis 2002, 186(12):1754-1760.
84. Shim J.K., Johnson S., Samore M.H., et al. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998, 351(9103):633-636.
85. Clabots C.R., Johnson S., Olson M.M., et al. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992, 166(3):561-567.
86. Santos R.P., Mayo T.W., Siegel J.D. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations. Clin Infect Dis 2008, 47(1):110-116.
87. Owens R.C. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis 2008, 61(1):110-128.
88. Briceland L.L., Nightingale C.H., Quintiliani R., et al. Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach. Arch Intern Med 1988, 148(9):2019-2022.
89. McGowan J.E., Finland M. Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis 1974, 130(2):165-168.
90. Evans R.S., Pestotnik S.L., Classen D.C., et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998, 338(4):232-238.
91. Carmeli Y., Samore M.H., Huskins C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med 1999, 159(20):2461-2468.
92. de Bruin M.A., Riley L.W. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 2007, 7:24.
93. Smith D.W. Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy 1999, 19(8 Pt 2):129S-132S. [discussion: 33S-7S].
94. Bonten M.J.M., Slaughter S., Ambergen A.W., et al. The role of " colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998, 158(10):1127-1132.
95. de Man P., Verhoeven B.A., Verbrugh H.A., et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000, 355(9208):973-978.
96. Meyer K.S., Urban C., Eagan J.A., et al. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993, 119(5):353-358.
97. Rahal J.J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998, 280(14):1233-1237.
98. Polgreen P.M., Chen Y.Y., Cavanaugh J.E., et al. An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia. Infect Control Hosp Epidemiol 2007, 28(2):212-214.
99. Khan R., Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J Hosp Infect 2003, 54(2):104-108.
100. McNulty C., Logan M., Donald I.P., et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother 1997, 40(5):707-711.
101. Valiquette L., Cossette B., Garant M.P., et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007, 45(s2):S112-S121.
102. Kallen Alexander J., Thompson A., Ristaino P., et al. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol 2009, 30(3):264-272.
103. Gross R., Morgan A.S., Kinky D.E., et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001, 33(3):289-295.
104. Fishman N. Antimicrobial stewardship. Am J Infect Control 2006, 34(5 Suppl 1):S55-S63. [discussion: S4-73].
105. Weber S.G., Gold H.S., Hooper D.C., et al. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003, 9(11):1415-1422.
106. Harris A.D., Lautenbach E., Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 2005, 41(1):77-82.
107. Perencevich E.N., Stone P.W., Wright S.B., et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007, 28(10):1121-1133.
108. Verity P., Wilcox M.H., Fawley W., et al. Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J Hosp Infect 2001, 49(3):204-209.
109. Lu P.L., Siu L.K., Chen T.C., et al. Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii on computer interface surfaces of hospital wards and association with clinical isolates. BMC Infect Dis 2009, 9:164.
110. Boyce J.M., Potter-Bynoe G., Chenevert C., et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997, 18(9):622-627.
111. Bode L.G.M., Kluytmans J.A.J.W., Wertheim H.F.L., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362(1):9-17.
112. Calderwood M.S., Mauer A., Tolentino J., et al. Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infect Control Hosp Epidemiol 2008, 29(11):1019-1025.